CAN DYSPLASIA SURVEILLANCE BE BETTER TARGETED BY USING FAECAL CALPROTECTIN MEASUREMENTS IN ULCERATIVE COLITIS?

Anna-Maija Puolanne  ¹     Sami Qadri  ²     Tiina Vesterinen     Saara Hiltunen  ³     Aaro Mustonen     Johanna Arola     Kaija-Leena Kolho     Martti A. Färkkilä    
¹ Helsinki University Hospital, Helsinki, Finland
² Minerva Foundation Institute for Medical Research, Helsinki, Finland
³ BCB Medical Ltd., Espoo, Finland

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)